|
|
|
A study on the use of Cell Cept, an
immunosuppressive drug, as an initial treatment for MG
is underway by Dr. Meriggioli at UIC. The three requirements for participating
in this study are:
1. No previous use of immuno-suppressive
drugs.
2. Generalized MG (not Ocular)
3. Acetylcholine receptor antibody
positive
If you meet these requirements and would
like to participate in this study call Judy Richman,
Study Coordinator, at 1
312 413 8605.
|
Myasthenia Gravis
Foundation of Illinois, Inc.©
300 North Elizabeth Street, Suite 610C,
Chicago, Illinois, 60607 - 1144
312 - 491-7809, 800-888-6208,
Fax: 312-491-7830
Monday through Friday, 9 AM to 5 PM CT.
Contact Us
|
Map |
Disclaimer
|
Privacy Policy
Copyright ©
MGFI 2003 - 2005, All rights reserved.
MGFI is a 501(c) (3) charity.
|
|
|
Calendar Club
Please call the office
if you would like to support the MGFI through the
Calendar Club. You may win one of the weekly
prizes! See
Calendar Club |
|
